Navigation Links
DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs
Date:8/4/2011

RADUR-ADHD and next steps in that program, anticipated initiation of clinical studies for Relday in early 2012 and potential milestone payments and royalties receivable from Zogenix, and the potential benefits and uses of our drug candidates are forward-looking statements involving risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, the risk of adverse decisions by regulatory agencies, including product non-approval, delays and additional costs due to requirements imposed by regulatory agencies, potential adverse effects arising from the testing or use of our drug candidates, the potential failure of our clinical trials to meet their intended endpoints, our potential failure to maintain our collaborative agreements with third parties or consummate new collaborations and DURECT's (and that of its third party collaborators where applicable) difficulty or failure to obtain approvals from regulatory agencies with respect to its development activities and products, or ability to design, enroll, conduct and complete clinical trials, complete the design, development, and manufacturing process development of the referenced product candidates, manufacture and commercialize the referenced product candidates, obtain marketplace acceptance of the referenced product candidates, avoid infringing patents held by other parties and secure and defend patents of our own, and manage and obtain capital to fund its growth, operations and expenses. Further information regarding these and other risks is included in DURECT's Form 10-Q on May 4, 2011 under the heading "Risk Factors."

DURECT CORPORATIONSTATEMENTS OF OPERATIONS DATA(in thousands, except per share amounts)(Unaudited)Three months ended Six months ended June 30, June 30, 2011201020112010Collaborative research and development and other revenue

$  5,188$  4,657$  1
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. DURECT Corporation Invites You to Join its Second Quarter 2011 Earnings Conference Call
2. DURECT to Present at the Jefferies Healthcare Conference
3. DURECT Announces Resignation of Chief Medical Officer
4. DURECT to Present at the UBS Global Specialty Pharmaceuticals Conference
5. DURECT Announces ELADUR® (TRANSDUR®-Bupivacaine) Phase II Study Results in Chronic Low Back Pain
6. DURECT to Present at Cowen and Company Health Care Conference
7. DURECT Corporation Invites You to Join its Fourth Quarter 2010 Earnings Conference Call
8. DURECT Reports Data From European Phase IIb Shoulder Study of POSIDUR™ (SABER™-Bupivacaine) and Amendment of the Nycomed Agreement
9. DURECT Announces Launch of First FDA Approved SABER™-Injectable Peptide Product
10. DURECT to Present at the BIO CEO & Investor Conference
11. DURECT to Present at the Credit Suisse 2010 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... -- Moms are ready to live the "measured life" ... kids, according to the results of the BabyCenter® U.S. ... for Moms, the latest installment in BabyCenter,s 21 st ... and parenting web and mobile destination worldwide, conducted the ... say they can,t think of a reason not to ...
(Date:10/22/2014)... Oregon , October 22, 2014 ... "Global Disposable Gloves Market (Product type, Form, End user, ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... global disposable gloves market. Based on key trends tracked, ... be valued at $7.9 billion by 2020, registering a ...
(Date:10/22/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... focused on the development of oral drug delivery ... its Phase IIa clinical trial of ORMD-0801, the ... 1 diabetes. The trial was conducted in ... Food and Drug Administration (FDA) Investigational New Drug ...
Breaking Medicine Technology:BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 2BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 3BabyCenter Finds Mom Ready to Live the "Measured Life" in its U.S. Mobile Mom 2014 Report: Health & Fitness Go Mobile for Moms 4Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4
...  Brainlab, a leader in software-driven medical technology, announced today ... at the University of California San Francisco (UCSF) Medical ... advanced neurosurgery procedures to help detect and remove brain ... is one of the top hospitals in the nation ...
... 2012  Lilly Diabetes and Walgreens are educating people ... common and misunderstood consequences of diabetes: hypoglycemia (low ... campaign at 43 Walgreens pharmacies throughout the Indianapolis ... about hypoglycemia that pharmacists may use when counseling ...
Cached Medicine Technology:UCSF Medical Center Treats Patients with New Brainlab Curve™ Image Guided Surgery 2UCSF Medical Center Treats Patients with New Brainlab Curve™ Image Guided Surgery 3Lilly Diabetes and Walgreens Launch Diabetes Hypoglycemia Awareness Campaign 2Lilly Diabetes and Walgreens Launch Diabetes Hypoglycemia Awareness Campaign 3
(Date:10/25/2014)... Background: , In 1998 Bob Savage founded ... pioneer in the field of establishing recovery community organizations. ... and when he retired, he set out to answer a ... , 1. Where are the people in ... , 2. Can the recovery community be organized to advocate ...
(Date:10/25/2014)... 25, 2014 QueenBeeTickets.com has a variety ... selection at affordable prices. Bob Seger & The Silver ... and Nationwide Arena are going on sale October 25 ... Here to browse the selection of tickets for ... , The famous singer is touring North America beginning ...
(Date:10/25/2014)... CT (PRWEB) October 25, 2014 Limbkeepers® ... upcoming episode of Innovations with Ed Begley Jr, airing ... times TBA. , In this episode, Innovations will focus ... helping to protect fragile, thinning skin on arms, hands, ... will learn about these versatile products, which help reduce ...
(Date:10/25/2014)... -- Researchers who discovered antibiotics in farmed and ... concern. The use of antibiotics in animals, ... contribute to the development of antibiotic-resistant bacteria that ... the study. Each year in the United ... and kill about 23,000, according to the Infectious ...
(Date:10/25/2014)... (HealthDay News) -- October,s shorter, darker days can trigger ... according to an expert. People affected by ... tired, lack motivation and even have trouble getting out ... suicide, said Dr. Angelos Halaris, a professor in the ... Chicago Stitch School of Medicine. "Seasonal affective disorder ...
Breaking Medicine News(10 mins):Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:QueenBeeTickets.com Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Dark Days Here for Folks With Seasonal Depression 2
... Pediatric Dengue Vaccine Initiative (PDVI), a program of the ... announced today their partnership to help develop and make ... of Dengue fever, the second most widespread tropical disease ... to which over 2 billion people are exposed and ...
... scientists at Dartmouth Medical School and Dartmouth College, have ... changing muscle metabolism and performance. // The researchers are ... of muscle diseases. , ,The researchers ... (or AMPK) is responsible for realizing the best muscle ...
... While kidney failure is a serious condition that ... these patients are prone to developing another grave ... Fibrosing Dermopathy (NSF/NFD). // First recognized as a ... or tightening of the skin, resulting in pain, ...
... after menopause, a change thought to be due, in part, ... // ,Now, research from the University of Michigan ... certain memory functions. In a study in the new issue ... that a group of postmenopausal women showed more brain activity ...
... who are overweight or obese have increased blood pressure ... risk of kidney damage previously found in this group ... at the American Society of Nephrology's 39th Annual Meeting ... demonstrated that filtration pressure in the kidney was higher ...
... two animal caretakers sent letters to city, state and federal ... not stringent //enough in treating waste from animals that died ... disease before it was sent to the city's sewage treatment ... request of the federal and city officials to study the ...
Cached Medicine News:Health News:Pediatric Dengue Vaccine Initiative and Hawaii Biotech Partner Against Dengue Fever 2Health News:Dartmouth researchers zero-in on a gene that heightens muscle performance 2Health News:Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition 2Health News:Hormone Therapy May Improve the Trip Down Memory Lane 2Health News:Kidney Blood Flow May Explain Increased Long-Term Risks for Obese Kidney Donors 2Health News:Complaints Against US Federal lab Over-ruled by Panel 2
Lead filled and faced bone mallet used to exert force on osteotomes, chisels, and gouges....
Straight curette with hollow handle and round cup....
Coarse rasp....
Rasp with down cutting pattern....
Medicine Products: